Global Bronchodilators Market Insights, Forecast to 2029

Publisher Name :
Date: 30-May-2023
No. of pages: 70
Inquire Before Buying

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.

The global Bronchodilators market is projected to grow from US$ 32680 million in 2023 to US$ 42270 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.

Report Includes:

This report presents an overview of global market for Bronchodilators, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Bronchodilators, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bronchodilators, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bronchodilators sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bronchodilators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bronchodilators sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and F. Hoffmann-La Roche, etc.

By Company

- AstraZeneca

- Boehringer Ingelheim

- GlaxoSmithKline

- F. Hoffmann-La Roche

Segment by Type

- Anticholinergic Bronchodilators

- Adrenergic Bronchodilators

- Bronchodilator Combinations

- Methylxanthines

Segment by Application

- Asthma

- COPD

- Others

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Bronchodilators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Bronchodilators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bronchodilators sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Bronchodilators Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Bronchodilators Product Introduction
1.2 Market by Type
1.2.1 Global Bronchodilators Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anticholinergic Bronchodilators
1.2.3 Adrenergic Bronchodilators
1.2.4 Bronchodilator Combinations
1.2.5 Methylxanthines
1.3 Market by Application
1.3.1 Global Bronchodilators Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bronchodilators Sales Estimates and Forecasts 2018-2029
2.2 Global Bronchodilators Revenue by Region
2.2.1 Global Bronchodilators Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bronchodilators Revenue by Region (2018-2023)
2.2.3 Global Bronchodilators Revenue by Region (2024-2029)
2.2.4 Global Bronchodilators Revenue Market Share by Region (2018-2029)
2.3 Global Bronchodilators Sales Estimates and Forecasts 2018-2029
2.4 Global Bronchodilators Sales by Region
2.4.1 Global Bronchodilators Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bronchodilators Sales by Region (2018-2023)
2.4.3 Global Bronchodilators Sales by Region (2024-2029)
2.4.4 Global Bronchodilators Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bronchodilators Sales by Manufacturers
3.1.1 Global Bronchodilators Sales by Manufacturers (2018-2023)
3.1.2 Global Bronchodilators Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bronchodilators in 2022
3.2 Global Bronchodilators Revenue by Manufacturers
3.2.1 Global Bronchodilators Revenue by Manufacturers (2018-2023)
3.2.2 Global Bronchodilators Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bronchodilators Revenue in 2022
3.3 Global Key Players of Bronchodilators, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bronchodilators Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bronchodilators, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bronchodilators, Product Offered and Application
3.8 Global Key Manufacturers of Bronchodilators, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bronchodilators Sales by Type
4.1.1 Global Bronchodilators Historical Sales by Type (2018-2023)
4.1.2 Global Bronchodilators Forecasted Sales by Type (2024-2029)
4.1.3 Global Bronchodilators Sales Market Share by Type (2018-2029)
4.2 Global Bronchodilators Revenue by Type
4.2.1 Global Bronchodilators Historical Revenue by Type (2018-2023)
4.2.2 Global Bronchodilators Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bronchodilators Revenue Market Share by Type (2018-2029)
4.3 Global Bronchodilators Price by Type
4.3.1 Global Bronchodilators Price by Type (2018-2023)
4.3.2 Global Bronchodilators Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bronchodilators Sales by Application
5.1.1 Global Bronchodilators Historical Sales by Application (2018-2023)
5.1.2 Global Bronchodilators Forecasted Sales by Application (2024-2029)
5.1.3 Global Bronchodilators Sales Market Share by Application (2018-2029)
5.2 Global Bronchodilators Revenue by Application
5.2.1 Global Bronchodilators Historical Revenue by Application (2018-2023)
5.2.2 Global Bronchodilators Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bronchodilators Revenue Market Share by Application (2018-2029)
5.3 Global Bronchodilators Price by Application
5.3.1 Global Bronchodilators Price by Application (2018-2023)
5.3.2 Global Bronchodilators Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bronchodilators Market Size by Type
6.1.1 US & Canada Bronchodilators Sales by Type (2018-2029)
6.1.2 US & Canada Bronchodilators Revenue by Type (2018-2029)
6.2 US & Canada Bronchodilators Market Size by Application
6.2.1 US & Canada Bronchodilators Sales by Application (2018-2029)
6.2.2 US & Canada Bronchodilators Revenue by Application (2018-2029)
6.3 US & Canada Bronchodilators Market Size by Country
6.3.1 US & Canada Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bronchodilators Sales by Country (2018-2029)
6.3.3 US & Canada Bronchodilators Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bronchodilators Market Size by Type
7.1.1 Europe Bronchodilators Sales by Type (2018-2029)
7.1.2 Europe Bronchodilators Revenue by Type (2018-2029)
7.2 Europe Bronchodilators Market Size by Application
7.2.1 Europe Bronchodilators Sales by Application (2018-2029)
7.2.2 Europe Bronchodilators Revenue by Application (2018-2029)
7.3 Europe Bronchodilators Market Size by Country
7.3.1 Europe Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bronchodilators Sales by Country (2018-2029)
7.3.3 Europe Bronchodilators Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bronchodilators Market Size
8.1.1 China Bronchodilators Sales (2018-2029)
8.1.2 China Bronchodilators Revenue (2018-2029)
8.2 China Bronchodilators Market Size by Application
8.2.1 China Bronchodilators Sales by Application (2018-2029)
8.2.2 China Bronchodilators Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bronchodilators Market Size by Type
9.1.1 Asia Bronchodilators Sales by Type (2018-2029)
9.1.2 Asia Bronchodilators Revenue by Type (2018-2029)
9.2 Asia Bronchodilators Market Size by Application
9.2.1 Asia Bronchodilators Sales by Application (2018-2029)
9.2.2 Asia Bronchodilators Revenue by Application (2018-2029)
9.3 Asia Bronchodilators Sales by Region
9.3.1 Asia Bronchodilators Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bronchodilators Revenue by Region (2018-2029)
9.3.3 Asia Bronchodilators Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bronchodilators Market Size by Type
10.1.1 Middle East, Africa and Latin America Bronchodilators Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bronchodilators Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bronchodilators Market Size by Application
10.2.1 Middle East, Africa and Latin America Bronchodilators Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bronchodilators Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bronchodilators Sales by Country
10.3.1 Middle East, Africa and Latin America Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bronchodilators Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bronchodilators Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 AstraZeneca Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Boehringer Ingelheim Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 F. Hoffmann-La Roche Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bronchodilators Industry Chain Analysis
12.2 Bronchodilators Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bronchodilators Production Mode & Process
12.4 Bronchodilators Sales and Marketing
12.4.1 Bronchodilators Sales Channels
12.4.2 Bronchodilators Distributors
12.5 Bronchodilators Customers
13 Market Dynamics
13.1 Bronchodilators Industry Trends
13.2 Bronchodilators Market Drivers
13.3 Bronchodilators Market Challenges
13.4 Bronchodilators Market Restraints
14 Key Findings in The Global Bronchodilators Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bronchodilators Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Anticholinergic Bronchodilators
Table 3. Major Manufacturers of Adrenergic Bronchodilators
Table 4. Major Manufacturers of Bronchodilator Combinations
Table 5. Major Manufacturers of Methylxanthines
Table 6. Global Bronchodilators Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Bronchodilators Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Bronchodilators Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Bronchodilators Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Bronchodilators Revenue Market Share by Region (2018-2023)
Table 11. Global Bronchodilators Revenue Market Share by Region (2024-2029)
Table 12. Global Bronchodilators Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Bronchodilators Sales by Region (2018-2023) & (K Units)
Table 14. Global Bronchodilators Sales by Region (2024-2029) & (K Units)
Table 15. Global Bronchodilators Sales Market Share by Region (2018-2023)
Table 16. Global Bronchodilators Sales Market Share by Region (2024-2029)
Table 17. Global Bronchodilators Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global Bronchodilators Sales Share by Manufacturers (2018-2023)
Table 19. Global Bronchodilators Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Bronchodilators Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Bronchodilators, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Bronchodilators Price by Manufacturers 2018-2023 (USD/Unit)
Table 23. Global Bronchodilators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Bronchodilators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchodilators as of 2022)
Table 25. Global Key Manufacturers of Bronchodilators, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Bronchodilators, Product Offered and Application
Table 27. Global Key Manufacturers of Bronchodilators, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 30. Global Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 31. Global Bronchodilators Sales Share by Type (2018-2023)
Table 32. Global Bronchodilators Sales Share by Type (2024-2029)
Table 33. Global Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Bronchodilators Revenue Share by Type (2018-2023)
Table 36. Global Bronchodilators Revenue Share by Type (2024-2029)
Table 37. Bronchodilators Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Bronchodilators Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 40. Global Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 41. Global Bronchodilators Sales Share by Application (2018-2023)
Table 42. Global Bronchodilators Sales Share by Application (2024-2029)
Table 43. Global Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Bronchodilators Revenue Share by Application (2018-2023)
Table 46. Global Bronchodilators Revenue Share by Application (2024-2029)
Table 47. Bronchodilators Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Bronchodilators Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Bronchodilators Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Bronchodilators Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Bronchodilators Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Bronchodilators Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada Bronchodilators Sales by Country (2024-2029) & (K Units)
Table 62. Europe Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 63. Europe Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 64. Europe Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 67. Europe Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 68. Europe Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Bronchodilators Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Bronchodilators Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Bronchodilators Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Bronchodilators Sales by Country (2018-2023) & (K Units)
Table 74. Europe Bronchodilators Sales by Country (2024-2029) & (K Units)
Table 75. China Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 76. China Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 77. China Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 80. China Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 81. China Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 84. Asia Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 85. Asia Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 88. Asia Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 89. Asia Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Bronchodilators Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Bronchodilators Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Bronchodilators Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Bronchodilators Sales by Region (2018-2023) & (K Units)
Table 95. Asia Bronchodilators Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Bronchodilators Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America Bronchodilators Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Bronchodilators Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Bronchodilators Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Bronchodilators Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Bronchodilators Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Bronchodilators Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Bronchodilators Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Bronchodilators Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Bronchodilators Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Bronchodilators Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Bronchodilators Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Bronchodilators Sales by Country (2024-2029) & (K Units)
Table 109. AstraZeneca Company Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca Bronchodilators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. AstraZeneca Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. AstraZeneca Recent Developments
Table 114. Boehringer Ingelheim Company Information
Table 115. Boehringer Ingelheim Description and Major Businesses
Table 116. Boehringer Ingelheim Bronchodilators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Boehringer Ingelheim Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Boehringer Ingelheim Recent Developments
Table 119. GlaxoSmithKline Company Information
Table 120. GlaxoSmithKline Description and Major Businesses
Table 121. GlaxoSmithKline Bronchodilators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. GlaxoSmithKline Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. GlaxoSmithKline Recent Developments
Table 124. F. Hoffmann-La Roche Company Information
Table 125. F. Hoffmann-La Roche Description and Major Businesses
Table 126. F. Hoffmann-La Roche Bronchodilators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. F. Hoffmann-La Roche Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. F. Hoffmann-La Roche Recent Developments
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Bronchodilators Distributors List
Table 132. Bronchodilators Customers List
Table 133. Bronchodilators Market Trends
Table 134. Bronchodilators Market Drivers
Table 135. Bronchodilators Market Challenges
Table 136. Bronchodilators Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Bronchodilators Product Picture
Figure 2. Global Bronchodilators Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bronchodilators Market Share by Type in 2022 & 2029
Figure 4. Anticholinergic Bronchodilators Product Picture
Figure 5. Adrenergic Bronchodilators Product Picture
Figure 6. Bronchodilator Combinations Product Picture
Figure 7. Methylxanthines Product Picture
Figure 8. Global Bronchodilators Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Bronchodilators Market Share by Application in 2022 & 2029
Figure 10. Asthma
Figure 11. COPD
Figure 12. Others
Figure 13. Bronchodilators Report Years Considered
Figure 14. Global Bronchodilators Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Bronchodilators Revenue 2018-2029 (US$ Million)
Figure 16. Global Bronchodilators Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Bronchodilators Revenue Market Share by Region (2018-2029)
Figure 18. Global Bronchodilators Sales 2018-2029 ((K Units)
Figure 19. Global Bronchodilators Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Bronchodilators Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Bronchodilators Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Bronchodilators Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Bronchodilators Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Bronchodilators Sales YoY (2018-2029) & (K Units)
Figure 25. China Bronchodilators Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Bronchodilators Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Bronchodilators Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Bronchodilators Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Bronchodilators Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Bronchodilators Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Bronchodilators in the World: Market Share by Bronchodilators Revenue in 2022
Figure 32. Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Bronchodilators Sales Market Share by Type (2018-2029)
Figure 34. Global Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 35. Global Bronchodilators Sales Market Share by Application (2018-2029)
Figure 36. Global Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Bronchodilators Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Bronchodilators Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Bronchodilators Revenue Share by Country (2018-2029)
Figure 42. US & Canada Bronchodilators Sales Share by Country (2018-2029)
Figure 43. U.S. Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Bronchodilators Sales Market Share by Type (2018-2029)
Figure 46. Europe Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 47. Europe Bronchodilators Sales Market Share by Application (2018-2029)
Figure 48. Europe Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 49. Europe Bronchodilators Revenue Share by Country (2018-2029)
Figure 50. Europe Bronchodilators Sales Share by Country (2018-2029)
Figure 51. Germany Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 52. France Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 56. China Bronchodilators Sales Market Share by Type (2018-2029)
Figure 57. China Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 58. China Bronchodilators Sales Market Share by Application (2018-2029)
Figure 59. China Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 60. Asia Bronchodilators Sales Market Share by Type (2018-2029)
Figure 61. Asia Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 62. Asia Bronchodilators Sales Market Share by Application (2018-2029)
Figure 63. Asia Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 64. Asia Bronchodilators Revenue Share by Region (2018-2029)
Figure 65. Asia Bronchodilators Sales Share by Region (2018-2029)
Figure 66. Japan Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 70. India Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Bronchodilators Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Bronchodilators Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Bronchodilators Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Bronchodilators Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Bronchodilators Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Bronchodilators Sales Share by Country (2018-2029)
Figure 77. Brazil Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Bronchodilators Revenue (2018-2029) & (US$ Million)
Figure 82. Bronchodilators Value Chain
Figure 83. Bronchodilators Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs